293480 — Hana Pharm Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Annual income statement for Hana Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	177,306	196,407	210,845	224,457	225,340
Cost of Revenue
Gross Profit	114,023	130,818	131,240	139,584	141,292
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	145,460	160,397	179,719	197,385	200,193
Operating Profit	31,845	36,010	31,126	27,072	25,147
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	28,495	35,847	30,718	27,907	25,394
Provision for Income Taxes
Net Income After Taxes	14,893	28,014	24,307	22,333	21,250
Net Income Before Extraordinary Items
Net Income	14,893	28,014	24,307	22,333	21,250
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	14,893	28,014	24,307	22,333	21,250
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	839	1,678	1,412	1,290	1,227
Dividends per Share